Phase I study of liposomal irinotecan (LY01610) in patients with advanced esophageal squamous cell carcinoma.
Yun LiuBo ZhangJianping XuXingyuan WangJialin TangJing HuangPublished in: Cancer chemotherapy and pharmacology (2021)
NCT04088604 at ClinicalTrials.gov.
Keyphrases